Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation

被引:46
作者
Ceccato, F. [1 ,2 ]
Artusi, C. [3 ]
Barbot, M. [1 ]
Lizzul, L. [1 ]
Pinelli, S. [1 ]
Costantini, G. [1 ]
Niero, S. [1 ]
Antonelli, G. [3 ]
Plebani, M. [3 ]
Scaroni, C. [1 ]
机构
[1] Univ Hosp Padova, Dept Med DIMED, Endocrinol Unit, Via Osped Civile, I-35128 Padua, Italy
[2] Univ Padua, Dept Neurosci DNS, Padua, Italy
[3] Univ Hosp Padova, Dept Med DIMED, Lab Med Unit, Padua, Italy
关键词
Cushing's syndrome; Dexamethasone; Liquid chromatography-tandem mass spectrometry; Diagnostic accuracy; URINARY FREE CORTISOL; GLUCOCORTICOID-RECEPTOR GENE; SUBCLINICAL CUSHINGS-SYNDROME; NIGHT SALIVARY CORTISOL; ADRENAL INCIDENTALOMA; EUROPEAN-SOCIETY; DIAGNOSTIC-ACCURACY; SCREENING-TESTS; COLLABORATION; POLYMORPHISM;
D O I
10.1007/s40618-020-01197-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim Dexamethasone Suppression Test (DST), recommended for Cushing's Syndrome (CS) diagnosis, explores the pituitary feedback to glucocorticoids. Its diagnostic accuracy could be affected by dexamethasone bioavailability, and therefore, we have developed and validated a dexamethasone threshold after 1-mg DST. Materials and methods We studied 200 subjects: 125 patients were considered retrospectively and 75 were enrolled prospectively as the validation cohort. Serum dexamethasone, Late Night Salivary Cortisol (LNSC), and Urinary Free Cortisol (UFC) were measured with LC-MS/MS. Normal LNSC and UFC levels were used to exclude CS. The lower 2.5th percentile of dexamethasone distribution in non-CS patients with cortisol <= 50 nmol/L after 1-mg DST was used as threshold. Results 16 patients were CS and 184 non-CS (108 adrenal incidentaloma and 76 excluded CS); 4.5 nmol/L resulted the calculated threshold. Cortisol after 1-mg DST confirmed high sensitivity (100% at 50 nmol/L cut-off) and moderate-low specificity (63%, increased to 91% at 138 nmol/L) to diagnose CS in the whole cohort of patients. We could reduce the number of false-positive results (from 10 to 6 and from 7 to 4 in AI and excluded CS) considering adequate dexamethasone levels. Dexamethasone levels were not affected by hypercortisolism, age, gender, smoke, weight, and creatinine. 6% of non-CS patients did not achieve adequate dexamethasone levels (40% of tests with serum cortisol > 138 nmol/L after 1-mg DST). Conclusions We developed and validated the routine dexamethasone measurement during 1-mg DST: it is independent from patient's clinical presentation, and it should be used to increase the specificity of serum cortisol levels.
引用
收藏
页码:1105 / 1113
页数:9
相关论文
共 46 条
[41]   Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy [J].
Terzolo, Massimo ;
Reimondo, Giuseppe ;
Chiodini, Iacopo ;
Castello, Roberto ;
Giordano, Roberta ;
Ciccarelli, Enrica ;
Limone, Paolo ;
Crivellaro, Claudio ;
Martinelli, Irma ;
Montini, Marcella ;
Disoteo, Olga ;
Ambrosi, Bruno ;
Lanzi, Roberto ;
Arosio, Maura ;
Senni, Sanzio ;
Balestrieri, Antonio ;
Solaroli, Erica ;
Madeo, Bruno ;
De Giovanni, Raffaella ;
Strollo, Felice ;
Battista, Rodolfo ;
Scorsone, Alessandro ;
Giagulli, Vito A. ;
Collura, Daniela ;
Scillitani, Aldo ;
Cozzi, Renato ;
Faustini-Fustini, Marco ;
Pia, Anna ;
Rinaldi, Roberta ;
Allasino, Barbara ;
Peraga, Giulia ;
Tassone, Francesco ;
Garofalo, Piernicola ;
Papini, Enrico ;
Borretta, Giorgio .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10) :3467-3475
[42]   Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome [J].
Trementino, Laura ;
Appolloni, Gloria ;
Concettoni, Carolina ;
Cardinaletti, Marina ;
Boscaro, Marco ;
Arnaldi, Giorgio .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (01) :35-42
[43]   Clinical and biochemical impact of BCL1 polymorphic genotype of the glucocorticoid receptor gene in patients with adrenal incidentalomas [J].
Tzanela, M. ;
Mantzou, E. ;
Saltiki, K. ;
Tampourlou, M. ;
Kalogeris, N. ;
Hadjidakis, D. ;
Tsagarakis, S. ;
Alevizaki, M. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (04) :395-400
[44]   Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test [J].
Ueland, Grethe A. ;
Methlie, Paal ;
Kellmann, Ralf ;
Bjorgaas, Marit ;
Asvold, Bjorn O. ;
Thorstensen, Ketil ;
Kelp, Oskar ;
Thordarson, Hrafnkell B. ;
Mellgren, Gunnar ;
Lovas, Kristian ;
Husebye, Eystein S. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 176 (06) :705-713
[45]   Concomitant Medication Use Can Confound Interpretation of the Combined Dexamethasone-Corticotropin Releasing Hormone Test in Cushing's Syndrome [J].
Valassi, Elena ;
Swearingen, Brooke ;
Lee, Hang ;
Nachtigall, Lisa B. ;
Donoho, Daniel A. ;
Klibanski, Anne ;
Biller, Beverly M. K. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12) :4851-4859
[46]   Identification of the BclI polymorphism in the glucocorticoid receptor gene:: association with sensitivity to glucocorticoids in vivo and body mass index [J].
van Rossum, EFC ;
Koper, JW ;
van den Beld, AW ;
Uitterlinden, AG ;
Arp, P ;
Ester, W ;
Janssen, JAMJL ;
Brinkmann, AO ;
de Jong, FH ;
Grobbee, DE ;
Pols, HAP ;
Lamberts, SWJ .
CLINICAL ENDOCRINOLOGY, 2003, 59 (05) :585-592